Why the study?
Do left stellate ganglionectomy and beta-blocker therapy reduce cardiac events in patients with idiopathic long QT syndrome?
Population
196 patients with idiopathic long QT syndrome, mean age 24 years, 64% female, multinational.
Design
Cohort
Follow-up
average 26 months
Authors
Loading...
Beta-blockers and left stellate ganglionectomy were associated with fewer events in LQTS; hypothesis-generating and requires prospective confirmation.
Do left stellate ganglionectomy and beta-blocker therapy reduce cardiac events in patients with idiopathic long QT syndrome?
This prospective international study identified key risk factors for syncope and sudden death in long QT syndrome and demonstrated the protective effects of beta-blockers and left stellate ganglionectomy.
Moss et al. (1985) studied this question.